Your browser doesn't support javascript.
Risk Factors for Multisystem Inflammatory Syndrome in Children: A Case-control Investigation.
Zambrano, Laura D; Wu, Michael J; Martin, Lora; Malloch, Lacy; Chen, Sabrina; Newhams, Margaret M; Kucukak, Suden; Son, Mary Beth; Sanders, Cameron; Patterson, Kayla; Halasa, Natasha; Fitzgerald, Julie C; Leroue, Matthew K; Hall, Mark; Irby, Katherine; Rowan, Courtney M; Wellnitz, Kari; Sahni, Leila C; Loftis, Laura; Bradford, Tamara T; Staat, Mary; Babbitt, Christopher; Carroll, Christopher L; Pannaraj, Pia S; Kong, Michele; Schuster, Jennifer E; Chou, Janet; Patel, Manish M; Randolph, Adrienne G; Campbell, Angela P; Hobbs, Charlotte V.
  • Zambrano LD; From the COVID-19 Response Team, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Wu MJ; From the COVID-19 Response Team, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Martin L; Division of Infectious Disease, Department of Pediatrics, Children's of Mississippi, University of Mississippi Medical Center, Jackson, Mississippi.
  • Malloch L; Division of Infectious Disease, Department of Pediatrics, Children's of Mississippi, University of Mississippi Medical Center, Jackson, Mississippi.
  • Chen S; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Newhams MM; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Kucukak S; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Son MB; Division of Immunology, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts.
  • Sanders C; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
  • Patterson K; Division of Infectious Disease, Department of Pediatrics, Children's of Mississippi, University of Mississippi Medical Center, Jackson, Mississippi.
  • Halasa N; Division of Infectious Disease, Department of Pediatrics, Children's of Mississippi, University of Mississippi Medical Center, Jackson, Mississippi.
  • Fitzgerald JC; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Leroue MK; Division of Critical Care Medicine, Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Hall M; Department of Pediatrics, Section of Critical Care Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Irby K; Division of Pediatric Critical Care Medicine, Nationwide Children's Hospital Columbus, Ohio.
  • Rowan CM; Section of Pediatric Critical Care, Department of Pediatrics, Arkansas Children's Hospital, Little Rock, Arkansas.
  • Wellnitz K; Division of Pediatric Critical Care, Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, Indiana.
  • Sahni LC; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Loftis L; Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.
  • Bradford TT; Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.
  • Staat M; Division of Cardiology, Department of Pediatrics, Louisiana State University Health Sciences Center and Children's Hospital of New Orleans, New Orleans, Louisiana.
  • Babbitt C; Department of Pediatrics, University of Cincinnati College of Medicine, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Carroll CL; Miller Children's and Women's Hospital of Long Beach, Long Beach, California.
  • Pannaraj PS; Division of Pediatric Critical Care, Connecticut Children's Hospital, Hartford, Connecticut.
  • Kong M; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Schuster JE; Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama.
  • Chou J; Department of Pediatrics, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
  • Patel MM; Division of Immunology, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts.
  • Randolph AG; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
  • Campbell AP; From the COVID-19 Response Team, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Hobbs CV; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.
Pediatr Infect Dis J ; 42(6): e190-e196, 2023 06 01.
Artículo en Inglés | MEDLINE | ID: covidwho-2288273
ABSTRACT

BACKGROUND:

In a 2020 pilot case-control study using medical records, we reported that non-Hispanic Black children were more likely to develop multisystem inflammatory syndrome in children (MIS-C) after adjustment for sociodemographic factors and underlying medical conditions. Using structured interviews, we investigated patient, household, and community factors underlying MIS-C likelihood.

METHODS:

MIS-C case patients hospitalized in 2021 across 14 US pediatric hospitals were matched by age and site to outpatient controls testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within 3 months of the admission date. Caregiver interviews queried race/ethnicity, medical history, and household and potential community exposures 1 month before MIS-C hospitalization (case-patients) or after SARS-CoV-2 infection (controls). We calculated adjusted odds ratios (aOR) using mixed-effects multivariable logistic regression.

RESULTS:

Among 275 case patients and 496 controls, race/ethnicity, social vulnerability and patient or family history of autoimmune/rheumatologic disease were not associated with MIS-C. In previously healthy children, MIS-C was associated with a history of hospitalization for an infection [aOR 4.8; 95% confidence interval (CI) 2.1-11.0]. Household crowding (aOR 1.7; 95% CI 1.2-2.6), large event attendance (aOR 1.7; 95% CI 1.3-2.1), school attendance with limited masking (aOR 2.6; 95% CI 1.1-6.6), public transit use (aOR 1.8; 95% CI 1.4-2.4) and co-resident testing positive for SARS-CoV-2 (aOR 2.2; 95% CI 1.3-3.7) were associated with increased MIS-C likelihood, with risk increasing with the number of these factors.

CONCLUSIONS:

From caregiver interviews, we clarify household and community exposures associated with MIS-C; however, we did not confirm prior associations between sociodemographic factors and MIS-C.
Asunto(s)

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Estudio observacional / Estudio pronóstico / Investigación cualitativa Límite: Niño / Humanos Idioma: Inglés Revista: Pediatr Infect Dis J Asunto de la revista: Enfermedades Transmisibles / Pediatría Año: 2023 Tipo del documento: Artículo País de afiliación: INF.0000000000003900

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Estudio observacional / Estudio pronóstico / Investigación cualitativa Límite: Niño / Humanos Idioma: Inglés Revista: Pediatr Infect Dis J Asunto de la revista: Enfermedades Transmisibles / Pediatría Año: 2023 Tipo del documento: Artículo País de afiliación: INF.0000000000003900